Is Epizyme Inc (EPZM) a Laggard in the Healthcare Sector?

Thursday, November 18, 2021 10:34 AM | InvestorsObserver Analysts

Mentioned in this article

Is Epizyme Inc (EPZM) a Laggard in the Healthcare Sector?

Epizyme Inc (EPZM) is around the middle of the Healthcare sector according to InvestorsObserver. EPZM received an overall rating of 3, which means that it scores higher than 3% of stocks. Additionally, Epizyme Inc scored a 42 in the Healthcare sector, ranking it higher than 42% of stocks in that sector.

EPZM has an Overall Score of 3. Find out what this means to you and get the rest of the rankings on EPZM!

See Full EPZM Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Epizyme Inc Stock Today?

Epizyme Inc (EPZM) stock is trading at $3.99 as of 10:31 AM on Thursday, Nov 18, a decline of -$0.11, or -2.58% from the previous closing price of $4.10. The stock has traded between $3.99 and $4.20 so far today. Volume today is low. So far 139,575 shares have traded compared to average volume of 854,861 shares. Click Here to get the full Stock Report for Epizyme Inc stock.